TERN THERAPEUTICS is a privately-held biotechnology company founded in 2023 with a new vision for speeding the development of transformative, one-time gene therapy medicines for rare diseases. Guided by a team of leading physicians, scientists, and business leaders and in collaboration with patient communities, we are driven to deliver transformative treatments with urgency to those living around the world with rare disease.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Washington, Dc, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.terntx.com
- HQ
- Washington, DC
Tern Therapeutics Questions
Tern Therapeutics's website is http://www.terntx.com
Tern Therapeutics's LinkedIn profile is https://www.linkedin.com/company/terntx
Tern Therapeutics has
5 employees.
View email and phone details for 5
employees at Tern Therapeutics.
Tern Therapeutics's industry is
Biotechnology Research
Tern Therapeutics's top competitors are
Gemma Biotherapeutics,
Bdsra Foundation,
Terns Pharmaceuticals,
Regenxbio,
Sera Medicines, Llc,
Circle Pharma, Inc.,
Jazz Pharmaceuticals,
Noetik,
Tern Biotec,
Franklin Biolabs.
Tern Therapeutics's categories are Biotechnology Research
Tern Therapeutics's founding year is 2023
